SCHEDULE Filed 2025-09-23 Event 2025-09-19 SEC 0001193125-25-213528 →

Versant Venture Capital VI, L.P. → LAVA Therapeutics NV

Stake: — Shares: — CUSIP: N51517105 Class: Common Shares, par value Euro 0.12 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

4 13D/G filings on this issuer

3 other filings besides this one

Filer Track Record

15 filings by this filer

14 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Other 13D/G Filings on LAVA Therapeutics NV

Filed	Form	Filer	Stake	Shares
2023-06-06	SC	Novo Holdings A/S	—	—	view →
2023-02-24	SC	Novo Holdings A/S	—	—	view →
2022-10-03	SC	Novo Holdings A/S	—	—	view →

Other Filings by Versant Venture Capital VI, L.P.

Filed	Form	Issuer	Stake	Shares
2026-01-09	SCHEDULE	Monte Rosa Therapeutics, Inc. GLUE	3.40%	2,236,708	view →
2025-11-12	SCHEDULE	Monte Rosa Therapeutics, Inc. GLUE	5.10%	3,334,669	view →
2025-08-13	SCHEDULE	Tempest Therapeutics, Inc. TPST	3.70%	162,972	view →
2025-02-11	SCHEDULE	Tempest Therapeutics, Inc. TPST	4.80%	2,118,644	view →
2022-01-13	SC	Oyster Point Pharma, Inc.	—	—	view →
2021-10-27	SC	Oyster Point Pharma, Inc.	—	—	view →
2021-06-21	SC	Aligos Therapeutics, Inc. ALGS	—	—	view →
2021-05-24	SC	Oyster Point Pharma, Inc.	—	—	view →
2021-05-03	SC	Aligos Therapeutics, Inc. ALGS	—	—	view →
2021-04-05	SC	Oyster Point Pharma, Inc.	—	—	view →
2021-03-01	SC	Oyster Point Pharma, Inc.	—	—	view →
2020-12-03	SC	Black Diamond Therapeutics, Inc. BDTX	—	—	view →
2020-11-23	SC	Black Diamond Therapeutics, Inc. BDTX	—	—	view →
2020-09-25	SC	Black Diamond Therapeutics, Inc. BDTX	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →